Functional and pharmacokinetic studies of tetrahydroaminoacridine in patients with amyotrophic lateral sclerosis
- 1 October 1990
- journal article
- research article
- Published by Hindawi Limited in Acta Neurologica Scandinavica
- Vol. 82 (4) , 253-258
- https://doi.org/10.1111/j.1600-0404.1990.tb01615.x
Abstract
Assuming the presence of clinically significant cholinergic hypofunction in amyotrophic lateral scleroses (ALS), seven patients with ALS were treated with 100–200 mg tetrahydroaminoacridine (THA) together with 11 g lecithin daily for up to 7 weeks. In a separate experiment pharmacokinetics and effects on muscle strength and neurophysiological parameters were studied following the injection of 30 mg THA intravenously. Following the injection of THA an increase in muscle strength was observed in two patients. There were no consistent pharmacokinetic differences that could explain the effect on intravenous THA on muscle strength in these two patients. The plasma clearance of THA was high and the oral bioavailability low with large interindividual differences (6–36%). No beneficial effect was seen during oral medication and side‐effects were common. There were no conclusive changes observed regarding neurophysiological parameters after drug administration. THA has probably no place in the treatment of ALS.Keywords
This publication has 14 references indexed in Scilit:
- Cholinergic, opioid and glycine receptor binding sites localized in human spinal cord by in vitro autoradiography Changes in amyotrophic lateral sclerosisActa Neurologica Scandinavica, 2009
- Determination of tacrine and its 1-hydroxy metabolite in plasma using column liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1989
- Tetrahydroaminoacridine selectively attenuates NMDA receptor-mediated neurotoxicityEuropean Journal of Pharmacology, 1988
- Guam Amyotrophic Lateral Sclerosis-Parkinsonism-Dementia Linked to a Plant Excitant NeurotoxinScience, 1987
- Oral Tetrahydroaminoacridine in Long-Term Treatment of Senile Dementia, Alzheimer TypeNew England Journal of Medicine, 1986
- Cholinesterase inhibitors lack therapeutic effect in amyotrophic lateral sclerosis. A controlled study of physostigmine versus neostigmineActa Neurologica Scandinavica, 1986
- PHARM—An interactive graphic program for individual and population pharmacokinetic parameter estimationComputers in Biology and Medicine, 1984
- Amyotrophic lateral sclerosis: Alterations in neurotransmitter receptorsAnnals of Neurology, 1983
- Choline acetyltransferase and substance P-like immuno-reactivity in the human spinal cord: changes in amyotrophic lateral sclerosisBrain Research, 1982
- The Cholinergic Hypothesis of Geriatric Memory DysfunctionScience, 1982